资讯 | 美加墨达成取代NAFTA的贸易协议。特斯拉(TSLA)产量达季度目标,股价大涨17.35%。

wechat omage

美股

截至北京时间10月2日凌晨,美股周一收盘涨跌不一。道指上涨192点,标普500指数逼近历史最高收盘纪录。美国与加拿大在最后时刻达成修订北美自由贸易协定(NAFTA)的框架协议,令市场情绪乐观。

截止收盘,指涨192.90点,或0.73%,报26,651.21点;标普500指数涨10.61点,或0.36%,报2,924.59点;纳指跌9.05点,或0.11%,报8,037.30点。

宏观基本面:

美加墨达成取代NAFTA的贸易协议

周一是第四季度的第一个交易日。美国与加拿大的贸易谈判出人意料地取得突破,令市场情绪乐观。美加达成框架协议的消息推动福特汽车(F)与通用汽车(GM)股价攀升。此外,波音(BA)、美国运通(AXP)等也随之上涨。

据了解相关谈判的消息人士表示,美国与加拿大在周日午夜最后期限之前达成协议,保留了由美加墨三国参与北美自由贸易协定(NAFTA)的格局,将使美国对加拿大乳制品市场的准入大幅提高,同时让加拿大避免美国可能开征的汽车关税。

美国还保留了对加拿大或墨西哥出口汽车超260万辆时征收关税的权利,与20世纪80年代控制汽车进口的举措遥相呼应,而经济学家认为这是误入歧途的做法。另外,新协定还包括更严格的药品知识产权保护规定和更长的专利有效期。特朗普政府表示,整体而言,美墨加协议(UMCA)将鼓励该地区制造业发展。这一切均符合特朗普在区域和全球范围内开打贸易战的目标。

焦点股关注:

特斯拉(TSLA)收盘大涨17.35%。该公司董事长兼CEO埃隆-马斯克(Elon Musk)与美国证券交易委员会就欺诈调查达成和解,他将被迫辞去董事长职务,并与特斯拉公司一共被罚款4000万美元。

通用电气(GE)收高7.09%。这家工业巨擘表示,其首席执行官John Flannery在担任该职位一年多后就被替换,Flannery在2017年6月成为公司首席执行官。

3个月产8万辆车!特斯拉产能已达季度目标

汽车新闻网站Electrek在周一开盘后援引知情人士报道称,特斯拉第三季度生产了5.3万辆Model 3轿车。这兑现了该公司8月份的承诺,即本季度将生产5万至5.5万辆Model 3汽车,而前三个月的产量为2.85万辆。

Elektrek还报告称,该公司Q3共生产了8万辆汽车,创历史新高,上一季度为5.3万辆。总体而言,特斯拉本季度的汽车产量几乎相当于前两个季度的总和。

在上个周末马斯克与美国证监会SEC达成和解,并放话公司接近盈利之后,周一特斯拉美股盘前暴涨19%,开盘后维持近17%的涨幅,完全抹去了上周五跌幅14%,对空头又是一记暴击。

 

 

   

港股

香港市场周一关闭。周二正常开放。

港股通方面,9月27日-10月7日均关闭,10月8日即星期一港股通开通。

沪、深港通方面,9月29日-10月7日关闭,10月8日正常开通。

 

 

中国A股

中国市场周一至周五关闭,下周一正常开市。

 
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com